Skip to content Skip to sidebar Skip to footer

Tech Stocks

Test text

starpharma
Starpharma (ASX: SPL) Soars 70% on Genentech Deal
Starpharma Lands Genentech Collaboration Starpharma (ASX: SPL) has caught investor attention with a stunning 70 percent share price surge after unveiling a collaboration with global biotech giant Genentech. At the heart of the deal is Starpharma’s DEP platform, which uses dendrimers—tiny, tree-like molecules designed to carry cancer drugs more effectively through the body. By “loading”…

Stocks Down Under (Pitt Street Research AFSL 1265112) provides actionable investment ideas on ASX-listed stocks. This content provides general information only and does not constitute financial advice. Always do your own research before making investment decisions. © 2026 Stock Down Under. All Rights Reserved.

© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here